Canadian Center for Functional Medicine Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Coquitlam Canada

Organization Overview

First Clinical Trial
2006
NCT00801814
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

oryza sativa (1 trial)

polyglycoplex (4 trials)

Drugs in Phase 2 Trials (2)

cellulose (1 trial)

soybean oil (Intralipid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 3)

Overweight (Phase 2)

Weight Loss (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4